Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy.
Saved in:
| Title: | Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: development and place in therapy. |
|---|---|
| Authors: | Keyel ME; Cancer Center, Patrick.Reynolds@ttuhsc.edu.; Department of Pediatrics, Patrick.Reynolds@ttuhsc.edu., Reynolds CP; Cancer Center, Patrick.Reynolds@ttuhsc.edu.; Department of Pediatrics, Patrick.Reynolds@ttuhsc.edu.; Department of Internal Medicine, Patrick.Reynolds@ttuhsc.edu.; Department of Cell Biology & Biochemistry, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA, Patrick.Reynolds@ttuhsc.edu. |
| Source: | Biologics : targets & therapy [Biologics] 2018 Dec 21; Vol. 13, pp. 1-12. Date of Electronic Publication: 2018 Dec 21 (Print Publication: 2019). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Dove Medical Press (NZ) Country of Publication: New Zealand NLM ID: 101321511 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5475 (Print) Linking ISSN: 11775475 NLM ISO Abbreviation: Biologics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1177-5475 |
|---|---|
| DOI: | 10.2147/BTT.S114530 |
